---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-019971"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2023-07-14T23:59:59+00:00"
generated_at: "2026-06-13T08:02:00.916273+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BIO-key receives additional 180-day Nasdaq compliance period until Jan 8, 2024 for bid price rule

## Summary
- Received deficiency letter on Jan 12, 2023 for bid price below $1.00 for 30 consecutive days.
- On July 12, 2023, Nasdaq granted additional 180-day period until Jan 8, 2024 to regain compliance.
- To regain compliance, closing bid price must be at least $1.00 for 10 consecutive business days.
- Company may effect reverse stock split to cure deficiency if needed.
- If not compliant by Jan 8, 2024, Nasdaq will delist and company can appeal.

## SEC filing metadata
- accession: 0001437749-23-019971
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2023-07-14T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774923019971/0001437749-23-019971-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774923019971/bkyi20230714_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-019971
- JSON: https://secwatch.observer/filing/0001437749-23-019971.json
- Plain text: https://secwatch.observer/filing/0001437749-23-019971.txt

## Key facts
- Listing & Compliance Notices
  BIO KEY INTERNATIONAL INC received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: extension granted
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: July 12, 2023, the Company received a letter from Nasdaq (the “Letter”) stating that although the Company had not regained compliance with the Bid Price Rule, Nasdaq determined that the Company is eligible for an additional 180-day period, or until January 8, 2024, to regain compliance with the Bid Price Rule. In the Letter, Nasdaq stated that its determination was based on (i) the Company meeting the continued listing requirement for market value of its publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the minimum
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774923019971/0001437749-23-019971-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.